Naveen Pemmaraju: Proud to be a part of the BPDCN chapter in the new WHO Book
Naveen Pemmaraju shared on X:
“It’s here! Out now hot off the press! The new WHO Book — super proud to be a part of this by contributing to the new BPDCN chapter! Monumental overall effort led by Joe Khoury et al.”
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network.
He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
